生物活性脱细胞腱源干细胞膜片促进前交叉韧带重建后移植物愈合
本研究在大鼠前交叉韧带重建(ACLR)模型中,将脱细胞腱源干细胞(dTDSC)膜片包裹肌腱移植物,评估其对移植物愈合的促进作用。结果显示dTDSC膜片组在术后2周和6周的隧道骨形成、移植物骨整合及生物力学性能均显著优于对照组,且免疫微环境向促修复表型倾斜。作者认为dTDSC膜片可能通过BMP-2/VEGF、巨噬细胞极化和MMP/TIMP调节等机制促进愈合,可作为无细胞替代方案。
要点
- dTDSC膜片脱细胞成功,去除98.4%核酸,保留胶原蛋白及生物活性因子。
- dTDSC膜片组移植物极限失效载荷和刚度显著高于对照组。
- dTDSC膜片组iNOS+细胞减少、CD206+细胞增多,MMP-1/MMP-13降低、TIMP-1升高。
核心结论
- dTDSC膜片包裹肌腱移植物可促进大鼠ACLR后移植物愈合,可能通过增强骨形成和血管生成、调节巨噬细胞极化和MMP/TIMP表达以及物理保护移植物实现。
- dTDSC膜片可减轻细胞移植的质量控制与安全性顾虑,可作为无细胞替代方案用于促进ACLR移植物愈合。
研究设计与样本
- 采用优化脱细胞方案制备dTDSC膜片。
- 共64只Sprague-Dawley大鼠行ACLR,随机分为dTDSC膜片包裹组(n=32)和对照组(n=32)。
- 术后2周和6周通过micro-CT、组织学和生物力学测试评估移植物愈合,并通过免疫组化评估iNOS+、CD206+细胞及MMP-1、MMP-13、TIMP-1表达。
主要发现
- 脱细胞成功去除98.4%核酸,同时保留胶原蛋白和生物活性因子;dTDSC膜片中BMP-2和VEGF表达与TDSC膜片相当(P > .05)。
- micro-CT显示dTDSC膜片组隧道骨形成显著多于对照组。
- dTDSC膜片组移植物骨整合更好、移植物中段完整性更高,极限失效载荷显著更高(16.58 ± 7.24 vs 8.93 ± 2.45 N;P = .002),刚度显著更高(11.97 ± 5.21 vs 6.73 ± 2.20 N/mm;P = .027)。
- dTDSC膜片组腱-骨界面和移植物中段iNOS+细胞显著减少、CD206+细胞显著增多,MMP-1和MMP-13表达降低、TIMP-1表达升高。
临床怎么用
- 作者认为dTDSC膜片可作为无细胞替代方案用于促进ACLR移植物愈合(原文结论:can be used as a cell-free alternative)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stem cell sheets provide a scaffold-free option for the promotion of graft healing after anterior cruciate ligament reconstruction (ACLR). However, cell viability, stability, and potential uncontrolled actions create challenges for clinical translation. The decellularization of cell sheets may overcome these problems as studies have shown that the natural extracellular matrix of stem cells is bioactive and can promote tissue repair. HYPOTHESIS: The decellularized tendon-derived stem cell (dTDSC) sheet can promote graft healing after ACLR. STUDY DESIGN: Controlled laboratory study. METHODS: An optimized decellularization protocol was developed to decellularize the TDSC sheets. A total of 64 Sprague-Dawley rats underwent ACLR with or without the dTDSC sheet wrapping the tendon graft (n = 32/group). At 2 and 6 weeks after surgery, graft healing was assessed by micro-computed tomography, histology, and biomechanical testing. The accumulation of iNOS+ and CD206+ cells and the expression of metalloproteinase 1 (MMP-1), MMP-13, and tissue inhibitor of metalloprotease 1 (TIMP-1) were assessed by immunohistochemistry. RESULTS: The decellularization was successful, with the removal of 98.4% nucleic acid while preserving the collagenous proteins and bioactive factors. The expression of bone morphogenetic protein 2 (BMP-2) and VEGF in the dTDSC sheet was comparable with the TDSC sheet (P > .05). Micro-computed tomography showed significantly more tunnel bone formation in the dTDSC sheet group. The dTDSC sheet group demonstrated better graft osteointegration and higher integrity of graft midsubstance with significantly higher ultimate failure load (16.58 ± 7.24 vs 8.93 ± 2.45 N; P = .002) and stiffness (11.97 ± 5.21 vs 6.73 ± 2.20 N/mm; P = .027). Significantly fewer iNOS+ cells but more CD206+ cells, as well as lower MMP-1 and MMP-13 but higher TIMP-1 expression, were detected at the tendon-bone interface and graft midsubstance in the dTDSC sheet group. CONCLUSION: An optimized decellularization protocol for producing bioactive dTDSC sheets was developed. Wrapping tendon graft with a dTDSC sheet promoted graft healing after ACLR, likely via enhancing bone formation and angiogenesis by BMP-2 and VEGF, modulating macrophage polarization and MMP/TIMP expression, and physically protecting the tendon graft. CLINICAL RELEVANCE: dTDSC sheets alleviate the quality control and safety concerns of cell transplantation and can be used as a cell-free alternative for the promotion of graft healing in ACLR.
引用
- Yao S, Liang Z, Lee YW, et al. Bioactive Decellularized Tendon-Derived Stem Cell Sheet for Promoting Graft Healing After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2023. PMID: 36592017. doi:10.1177/03635465221135770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。